Abstract
Imaging small polar metabolites and analyzing their in vivo dynamics with stable isotope labeled (SIL) tracing through various biochemical pathways, including citric acid (TCA) cycle, glycolysis, and amino acid metabolism, has gained substantial interest over the years. However, imaging these small polar metabolites across different tissue types is limited due to their lower ionization efficiencies and ion suppression from larger abundant biomolecules. These challenges can be further exacerbated with SIL studies, which require improvements in sample preparation and method sensitivity. Solvent pretreatments before matrix application on a tissue section have the potential to improve the sensitivity of metabolite imaging, however, they are not yet widely optimized across tissue types. Further there is recurring concern about metabolite delocalization from such wash treatments which require ‘spatial validation’. Here, we optimized a simple ‘basic hexane’ wash method that improved sensitivity up to several folds for a broad range of polar and 2H labeled metabolites across five different mouse organ tissues (kidney, heart, brain, liver, and brown adipose tissue). Notably, we provided region-specific quantification of 51 metabolites using laser-microdissection (LMD)-LC-MS/MS to validate their localization observed in MALDI-MSI analysis after basic hexane wash. Overall, we reported an improved MALDI-MSI sample pretreatment method with ‘spatial validation’ workflow for sensitive and robust imaging of polar metabolite distributions in mouse organs.
Supplementary materials
Title
Supplementary Figures
Description
Supplementary figures information include solvent post-wash analysis, solvent mixtures studied, optimized basic additive concentrations and the volume of basic hexane required, ionization efficiency of selective metabolites at varying pH ranges, H&E staining images, comparative heatmap of metabolite signal intensities from all five organ tissues studied, LMD LC-MS/MS method optimization on liver, comparison of MALDI-MSI and LMD-LC-MS/MS analysis in three distinct tissue regions of the kidney, MS ion images of labeled metabolites annotated in all studied tissues.
Actions
Title
Supplementary methods
Description
Supplementary methods information include materials, animal experimentation, tissue preparation, matrix application, data acquisition and analysis using MALDI-MS imaging, Hematoxylin and eosin (H&E) staining, tissue sampling by laser capture microdissection, sample preparation, LC-MS/MS based method, data analysis for LMD-LC-MS/MS metabolomics, BCA protein assay, comparison between MALDI-MSI and LMD-LC-MS/MS analysis
Actions
Title
Supplementary Tables
Description
Summary of metabolite coverage from various wash conditions tested from each tissue type studied, pathways mapping, BCA protein estimation of liver tissue post wash and LMD kidney tissue sections, list of unlabeled and labeled metabolites detected among tissue types upon different solvent pretreatment, comparative metabolite intensity values from LipostarMSI and METASPACE, reproducibility of basic hexane wash protocol in kidney tissues, on-tissue MALDI-MS/MS, Optimization of liver tissue for LMD-LCMS workflow pre and post-basic hexane, Region-specific metabolite abundances from MALDI and LMD-LCMS of kidney washed with basic hexane. (Excel file)
Actions